Predictive Mortality of the Prognostic Nutritional Index Combined with APACHE II Score for Critically Ill Tuberculosis Patients
- PMID: 39288766
- PMCID: PMC11542510
- DOI: 10.4269/ajtmh.23-0661
Predictive Mortality of the Prognostic Nutritional Index Combined with APACHE II Score for Critically Ill Tuberculosis Patients
Abstract
High mortality rates are commonly found in critically ill patients with tuberculosis (TB), which is due partially to limitations in the existing prognostic evaluation methods. Therefore, we aimed to find more effective prognostic evaluation tools to reduce the mortality rate. Data from critically ill patients with TB admitted to the intensive care unit of The Second Hospital of Nanjing, Nanjing, China, between January 2020 and December 2022 were analyzed retrospectively. A total of 115 patients were enrolled and divided into a survival group (n = 62) and a death group (n = 53) according to 30-day survival. Univariate and least absolute shrinkage and selection operator (LASSO) regression analyses were used to investigate the risk factors for 30-day death in critically ill patients with TB. A prediction model for risk of 30-day mortality was developed for critically ill patients with TB in the intensive care unit. The LASSO regression model showed that the prognostic nutritional index (PNI) and Acute Physiology and Chronic Health Status (APACHE II) scores on the third day after admission to the intensive care unit were independent risk factors for 30-day mortality in critically ill patients with TB (P <0.05). The area under the curve value and that PA3 represents the combination of the PNI and APACHE II score on the third day, which was 0.952 (95% CI: 0.913-0.991, P <0.001), was significantly higher than that of the PNI or the APACHE II score on the third day. The new model is as follows: PA3 = APACHE II score (on the third day) × 0.421 - PNI × 0.204. The PNI combined with the APACHE II score on the third day could well predict the 30-day mortality risk of critically ill patients with TB.
Conflict of interest statement
Authors’ contributions: Q. Yuan participated in the conception, proposal development, data collection, and writing of the original draft. W. Li and K. Yang participated in acquisition of data, analysis, and interpretation of data for the work, and W. Li helped with the English. J. Guo and Y. Zheng participated in drafting the article or revising it critically for important intellectual content. All authors read and approved the final version of the manuscript.
Disclosure: The study was approved by the Ethics Committee of The Second Hospital of Nanjing (2020-LS-ky019). Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.
Figures
References
-
- Peloquin CA, Davies GR, 2021. The treatment of tuberculosis. Clin Pharmacol Ther 110: 1455–1466. - PubMed
-
- Tatar D, Senol G, Kirakli C, Edipoglu O, Cimen P, 2018. Contributing factors to mortality rates of pulmonary tuberculosis in intensive care units. J Chin Med Assoc 81: 605–610. - PubMed
-
- Lin SM, Wang TY, Liu WT, Chang CC, Lin HC, Liu CY, Wang CH, Huang CD, Lee KY, Kuo HP, 2009. Predictive factors for mortality among non-HIV-infected patients with pulmonary tuberculosis and respiratory failure. Int J Tuberc Lung Dis 13: 335–340. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
